Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION AND METHOD FOR TREATING DIABETES
Document Type and Number:
WIPO Patent Application WO2003033808
Kind Code:
A3
Abstract:
The present invention comprises dosing regimens and formulations of islet cell neogenesis associated protein (INGAP) and INGAP Peptide. The formulation disclosed herein is shown have acceptable stability as a pharmaceutical composition. Further, the formulation is able to regenerate functional islets

Inventors:
VINIK AARON I
ROSENBERG LAWRENCE
PITTENGER GARY
TAYLOR-FISHWICK DAVID
SALEM MICHAEL
MOHRLAND SCOTT
Application Number:
US0232904W
Publication Date:
September 18, 2003
Filing Date:
October 15, 2002
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GMP ENDOTHERAPEUTICS, INC.
International Classes:
A61K38/00; A61K31/00; A61P3/10; C07K14/47; (IPC1-7): A61K38/17
Domestic Patent References:
WO1996026215A11996-08-29
Foreign References:
US20020127624A12002-09-12
Other References:
RAFAELOFF RONIT ET AL: "Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters", JOURNAL OF CLINICAL INVESTIGATION, NEW YORK, NY, US, vol. 99, no. 9, 1997, pages 2100 - 2109, XP002173530, ISSN: 0021-9738
TAM J ET AL: "Islet-Neogenesis-Associated Protein Enhances Neurite Outgrowth from DRG Neurons", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 291, 1 March 2002 (2002-03-01), pages 649 - 654, XP002226504, ISSN: 0006-291X
Download PDF: